Xinyi Xie

A case of hypertensive retinopathy developing during pembrolizumab treatment for intrahepatic cholangiocarcinoma

To report the first documented case of severe vision loss due to secondary hypertensive retinopathy associated with pembrolizumab therapy, thereby expanding the known spectrum of ocular toxicities from immune checkpoint inhibitors (ICIs). A 54-year-old woman with intrahepatic cho...